Literature DB >> 20732599

Canine degenerative myelopathy.

Joan R Coates1, Fred A Wininger.   

Abstract

Canine degenerative myelopathy (DM) is an adult-onset fatal neurodegenerative disease that occurs in many breeds. The initial upper motor neuron spastic paraparesis and general proprioceptive ataxia in the pelvic limbs progress to a flaccid lower motor neuron tetraparesis. Recently, a missense mutation in the superoxide dismutase 1 (SOD1) gene was found to be a risk factor for DM, suggesting that DM is similar to some forms of human amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). This article reviews the current knowledge of canine DM with regard to its signalment, clinical spectrum, diagnostic approach, and treatment. The implications of the SOD1 mutation on both diseases are discussed, comparing pathogenic mechanisms while conveying perspectives to translational medicine. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20732599     DOI: 10.1016/j.cvsm.2010.05.001

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  35 in total

1.  The chaperone protein clusterin may serve as a cerebrospinal fluid biomarker for chronic spinal cord disorders in the dog.

Authors:  Intan N F Shafie; Mark McLaughlin; Richard Burchmore; Mary Ann A Lim; Paul Montague; Pamela E J Johnston; Jacques Penderis; Thomas J Anderson
Journal:  Cell Stress Chaperones       Date:  2013-08-29       Impact factor: 3.667

Review 2.  The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes.

Authors:  Javier Fernández-Ruiz
Journal:  Br J Pharmacol       Date:  2018-07-08       Impact factor: 8.739

3.  Degenerative myelopathy in German Shepherd Dog: comparison of two molecular assays for the identification of the SOD1:c.118G>A mutation.

Authors:  Maria Teresa Capucchio; Veronica Spalenza; Elena Biasibetti; Maria Teresa Bottero; Roberto Rasero; Alessandra Dalmasso; Paola Sacchi
Journal:  Mol Biol Rep       Date:  2014-01-05       Impact factor: 2.316

4.  Characterization of intercostal muscle pathology in canine degenerative myelopathy: a disease model for amyotrophic lateral sclerosis.

Authors:  Brandie R Morgan; Joan R Coates; Gayle C Johnson; Alyssa C Bujnak; Martin L Katz
Journal:  J Neurosci Res       Date:  2013-09-16       Impact factor: 4.164

5.  Selecting Quality Service Dogs: Part 1: Morphological and Health Considerations.

Authors:  Lindsay Parenti; Matthew Wilson; Anne M Foreman; Oliver Wirth; B Jean Meade
Journal:  APDT Chron Dog       Date:  2015

6.  Canine degenerative myelopathy: biochemical characterization of superoxide dismutase 1 in the first naturally occurring non-human amyotrophic lateral sclerosis model.

Authors:  Matthew J Crisp; Jeffrey Beckett; Joan R Coates; Timothy M Miller
Journal:  Exp Neurol       Date:  2013-05-23       Impact factor: 5.330

7.  Variants within the SP110 nuclear body protein modify risk of canine degenerative myelopathy.

Authors:  Emma L Ivansson; Kate Megquier; Sergey V Kozyrev; Eva Murén; Izabella Baranowska Körberg; Ross Swofford; Michele Koltookian; Noriko Tonomura; Rong Zeng; Ana L Kolicheski; Liz Hansen; Martin L Katz; Gayle C Johnson; Gary S Johnson; Joan R Coates; Kerstin Lindblad-Toh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

8.  Lumbar spinal cord microglia exhibited increased activation in aging dogs compared with young adult dogs.

Authors:  Christine M Toedebusch; Virginia B Garcia; John C Snyder; Maria R Jones; David J Schulz; Gayle C Johnson; Eric Villalón; Joan R Coates; Michael L Garcia
Journal:  Geroscience       Date:  2019-12-11       Impact factor: 7.713

9.  Characterization of thoracic motor and sensory neurons and spinal nerve roots in canine degenerative myelopathy, a potential disease model of amyotrophic lateral sclerosis.

Authors:  Brandie R Morgan; Joan R Coates; Gayle C Johnson; G Diane Shelton; Martin L Katz
Journal:  J Neurosci Res       Date:  2013-12-21       Impact factor: 4.164

Review 10.  SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments.

Authors:  Peter I Joyce; Pietro Fratta; Elizabeth M C Fisher; Abraham Acevedo-Arozena
Journal:  Mamm Genome       Date:  2011-06-26       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.